Streetbeat News

Equity Actions

SDRL

Seadrill Limited has announced an additional $250 million share repurchase authorization, signaling confidence in the company's financial stability and a commitment to returning value to shareholders.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 10:28 pm

IBIO

The board of iBio has approved a 20-to-1 reverse stock split of its common stock, which is expected to begin trading on a split-adjusted basis on November 29, 2023, under the new CUSIP number 451033708.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 10:22 pm

SRE

Trevor I. Mihalik, currently the Executive Vice President and CFO of Sempra, has been appointed to the position of Executive Vice President and Group President, effective January 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:40 pm

INTT

The Board of Directors of inTEST Corporation has authorized a stock repurchase plan, allowing the company to buy back up to $10 million of its common stock until November 17, 2024. This move could indicate the company's confidence in its financial stability and future prospects, and may be aimed at increasing shareholder value by reducing the number of shares outstanding, potentially leading to an increase in earnings per share.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:16 pm

TENB

Tenable Holdings, Inc. (NASDAQ:TENB) has announced a share repurchase program authorizing the buyback of up to $100 million of its Common Stock. The decision reflects the company's confidence in its financial health, citing increased operating margins and unlevered free cash flow as sources for the investment. The repurchase program is part of Tenable's strategy to enhance stockholder value, with no set expiration date for the authorization.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:09 pm

HSCS

The Icahn School of Medicine at Mount Sinai reported a 9.9% stake in Heart Test Laboratories as of November 16, 2023, according to a 13G filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:06 pm

SVRE

SaverOne has announced a proposed underwritten public offering. The company is likely seeking to raise capital, although the terms, pricing, and timing were not disclosed in the article.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:01 pm

COST

Benzinga's options scanner observed unusual options activity for Costco Wholesale (NASDAQ:COST), with a mix of bearish and bullish sentiment among big-money investors. A total of 26 uncommon options trades were detected, with 8 puts and 18 calls, indicating a price target range of $260 to $660 for COST over the next three months. The largest trades included both bullish and bearish positions with various expiration dates and strike prices. Costco operates a successful membership-based retail model and holds a significant market share. Its stock is slightly up with a potential overbought RSI indicator, and earnings are expected in 17 days. Analysts have given mixed reviews with an average target price of $600, with ratings ranging from Overweight to Outperform.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 7:46 pm

ASST

AVXL

BDRX

PGY

RDHL

RILY

U.S. stocks traded mixed with the Dow down 0.13%, NASDAQ up 0.11%, and S&P 500 down 0.08%. Real estate shares rose by 0.5%, while energy shares fell by 1.1%. U.S. new home sales declined by 5.6%. RedHill Biopharma's shares spiked 214% due to FDA market exclusivity for Talicia. Biodexa Pharmaceuticals surged 131% after acquiring a license for tolimidone. Asset Entities gained 80% after announcing a stock repurchase program. Pagaya Technologies fell 5.5% as CFO stepped down. B. Riley Financial dropped 9% despite Friday's gains. Anavex Life Sciences fell 8% after Q4 results. Oil was down 0.5%, gold up 0.5%, and silver up 1.4%. European and Asian markets closed lower.

Portfolio Pulse from Lisa Levin

November 27, 2023 | 7:30 pm

ASML

ASML Holding (NYSE:ASML) has seen a decrease in short interest, with the short percent of float falling 6.52% since the last report. The company has 1.72 million shares sold short, representing 0.43% of available shares, with a cover time of 1.4 days. This decline in short interest may indicate a more bullish sentiment among investors, although it does not necessarily predict a near-term price rise. ASML's short interest is below its peer group average of 6.73%.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 7:15 pm